Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 +0.16 (+0.51%)
As of: Sep 29, 2026 · 3:59 PM EDT

Celldex Therapeutics (CLDX) FCF Margin (2010 - 2026)

Updated

Celldex Therapeutics' FCF Margin came in at -275359.09% for Q2 2026, down 269231.28 percentage points from -6127.81% a year earlier but up 172900.91 percentage points from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) FCF Margin (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported FCF Margin of -153232.28%, down 149977.50 percentage points year-over-year; for FY2025, it was -13829.06%, down 11554.18 percentage points from FY2024.

  • FCF Margin carries a five-year change of -13263.46 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -2274.89% in FY2024 (-689.69 pp), -1585.20% in FY2023 (+2893.38 pp), -4478.57% in FY2022 (-3142.13 pp) and -1336.44% in FY2021 (-770.85 pp).
  • The five-year range for quarterly FCF Margin is -448260.00% (Q1 2026) to -803.66% (Q4 2023).
  • Year-over-year, FCF Margin has declined for three consecutive quarters, with an average year-over-year change of -107107.21 percentage points over the last seven quarters.
  • The fastest year-over-year change in FCF Margin over five years came in Q1 2025 (a gain of 18409.07 percentage points), and the weakest in Q1 2026 (a drop of 440398.56 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Celldex Therapeutics 2.47 Bn 2.47 Bn - -275,359.09%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -275,359.09%
Mar 31, 2026 -448,260.00%
Dec 31, 2025 -53,901.65%
Jun 30, 2025 -6,127.81%
Mar 31, 2025 -7,861.44%
Dec 31, 2024 -2,828.26%
Sep 30, 2024 -1,751.24%
Jun 30, 2024 -1,184.99%
Mar 31, 2024 -26,270.51%
Dec 31, 2023 -803.66%
Sep 30, 2023 -1,262.36%
Jun 30, 2023 -10,300.75%
Mar 31, 2023 -3,014.89%
Dec 31, 2022 -1,363.73%
Sep 30, 2022 -8,731.45%
Jun 30, 2022 -14,059.51%
Mar 31, 2022 -14,430.46%
Dec 31, 2021 -4,454.19%
Sep 30, 2021 -10,821.57%
Jun 30, 2021 -346.93%
API Access

Celldex Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CLDX&period=max&api_key=YOUR_API_KEY